Pathologic response to preoperative transarte- rial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection

作     者：Kwang Yeol Paik Eung Kook Kim 

作者机构：Department of Surgery Yeouido St.Mary’s Hospital The Catholic University of Korea College of Medicine 

出 版 物：《Hepatobiliary & Pancreatic Diseases International》 (国际肝胆胰疾病杂志（英文版）)

年 卷 期：2016年第15卷第2期

页      面：122-124页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：recurrence cirrhosis preoperative frequent extrahepatic cirrhotic dissemination potentially metastases necrotic 

摘      要：Hepatocellular carcinoma （HCC） is one of the most frequent complications in patients with .liver cirrhosis. HCC without cirrhosis is rareand obviously a different entity. Treatment depends on tumor stage, liver function and general performance. Results of locoregional treatment, resection or liver transplantation are superior to those of medical therapy. Surgical approaches are potentially curative. Underlying cirrhosis is usually the limiting factor for the extent of resection and persists after resection. Liver transplantation eliminates both cirrhosis and, potentially, the tumor. Whereas surgery （functional liver capacity provided） may be performed even in advanced tumors, liver transplantation is advocated in less advanced （T2） tumors in order to keep the rate of recurrent tumor low. Responsible use of scarce grafts requires sticking to this rule.